Extended indication Hypercholesterolemie, gemengde dyslipidemie, preventie van ernstige coronaire incidenten (Primary H
Therapeutic value No judgement

Product

Active substance Anacetrapib
Domain Cardiovascular diseases
Extended indication Hypercholesterolemie, gemengde dyslipidemie, preventie van ernstige coronaire incidenten (Primary Hypercholesterolaemia or mixed dyslipidaemia, including reduction in cardiovascular mortality and morbidity in patients at high risk of CV events, in combination with a statin).
Manufacturer MSD
Additional remarks November 2017: Fabrikant geeft aan dat er geen aanvraag ingediend gaat worden.

Registration

There is currently nothing known about registration.

Therapeutic value

Therapeutic value No judgement
Duration of treatment Not found

Expected patient volume per year

There is currently nothing known about the expected patient volume.

Expected cost per patient per year

There is currently nothing known about the expected cost.

Potential total cost per year

There is currently nothing known about the possible total cost.

Off label use

There is currently nothing known about off label use.

Indication extension

There is currently nothing known about indication extensions.

Other information

There is currently no futher information available.